Indian experts clear Russia's Sputnik V vaccine for use
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023
Indian experts clear Russia's Sputnik V vaccine for use

Coronavirus chronicle

TBS Report
12 April, 2021, 04:10 pm
Last modified: 12 April, 2021, 04:48 pm

Related News

  • India's Adani says $2.5 bln share sale on track even as bankers mull changes
  • India's rapid take-up of electric vehicles prompts rethink about long-term fuel needs
  • India's low coal stocks threaten electricity supply: Kemp
  • Holiday trips within China surge after lifting of Covid curbs
  • Two IAF aircraft crash near India's Madhya Pradesh's Morena

Indian experts clear Russia's Sputnik V vaccine for use

Sputnik V, manufactured in India by Dr Reddy's, has the highest effectiveness - 91.6% - after the Moderna and Pfizer shots

TBS Report
12 April, 2021, 04:10 pm
Last modified: 12 April, 2021, 04:48 pm
A nurse prepares Russia's "Sputnik-V" vaccine for inoculation in a post-registration trials stage at a clinic in Moscow. Photo: Reuters
A nurse prepares Russia's "Sputnik-V" vaccine for inoculation in a post-registration trials stage at a clinic in Moscow. Photo: Reuters

Sputnik V, the Covid-19 vaccine developed by Russia has been recommended for use in India by a committee of experts in the middle of a record spike in virus cases in the country.

If approved by regulator DCGI, Sputnik V will become the third vaccine to be used in India after Serum Institute of India's Covishield - developed by Oxford-AstraZeneca - and Bharat Biotech's Covaxin, reports the NDTV.

Sputnik V, manufactured in India by Dr Reddy's, has the highest effectiveness - 91.6%  - after the Moderna and Pfizer shots. Dr Reddy's had applied on 19 February for emergency use of the vaccine, which is in Phase 3 of clinical trials in India.

After the Subject Expert Committee (SEC)'s recommendation, the vaccine has to be greenlit by the Drug Controller General of India before it can be widely used to inoculate citizens. In its last meeting on 1 April, the committee had asked Dr Reddy's to submit data on how the shot activates the body's immune response against the coronavirus.

The panel had also asked unblinded data of all the serious adverse events; "unblended" means when subjects know whether the shot administered to them was the vaccine or a placebo. A comparative analysis of phase III data generated on the Indian and Russian studies at various times was also sought.

In India, Sputnik-V trials are on for around 1,600 people between 18 and 99.

The vaccine is also in trials in the UAE, Venezuela and Belarus.

Sputnik-V, named after the first Soviet Space satellite, works on the principle of a weakened Covid virus delivering parts of a pathogen that triggers an immune response in the body.

The two-dose vaccine, developed by Russia's Gamaleya Institute, costs less than $10 for each shot in international markets.

The dry form of the vaccine can be stored at 2 to 8 degrees.

The clearance has come on a day India recorded 1,68,912 new Covid cases in 24 hours, the sixth record rise in seven days, pushing the country's caseload to over 1.35 crore.

Indian government officials have reportedly said five more vaccines will be in use in India by October.

Top News

Sputnik Covid-19 Vaccine / India / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    Economic slump drags down growth in VAT collection from big cos
  • It's corruption that bites business harder: CPD
    It's corruption that bites business harder: CPD
  • Import slowdown to affect economic growth: ADB country head
    Import slowdown to affect economic growth: ADB country head

MOST VIEWED

  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent
  • Sean Bagley, 14, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    Updated Covid vaccines prevented illness from latest variants -CDC

Related News

  • India's Adani says $2.5 bln share sale on track even as bankers mull changes
  • India's rapid take-up of electric vehicles prompts rethink about long-term fuel needs
  • India's low coal stocks threaten electricity supply: Kemp
  • Holiday trips within China surge after lifting of Covid curbs
  • Two IAF aircraft crash near India's Madhya Pradesh's Morena

Features

Nandita Sharmin's journey to give organic skincare a new identity

Nandita Sharmin's journey to give organic skincare a new identity

13h | Mode
Illustration: TBS

'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

16h | Panorama
Photo: Bloomberg

BuzzFeed and AI are a match made in fad city

15h | Panorama
Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

1d | Panorama

More Videos from TBS

Sarika Sabrin is waiting for a good film

Sarika Sabrin is waiting for a good film

6h | TBS Entertainment
Take your football game to the next level at Next Level academy

Take your football game to the next level at Next Level academy

7h | TBS SPORTS
“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

9h | TBS Round Table
What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

1d | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

4
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

5
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]